Dr. Lance Berman
Lance Berman is Chief Medical Officer of Pulmocide and brings more than 25 years of experience in clinical development, medical affairs, and corporate leadership from his time in big pharma and in the small biotech start-up space. Most recently, Lance was Chief Medical Officer and Senior Vice President at Relypsa in the San Francisco Bay Area where he was responsible for building and leading the company’s clinical development, medical affairs, and drug safety functions. He also played a key role in the preparation and execution of the company’s IPO. In addition to having worked across multiple therapeutic areas in clinical development, he has worked closely with commercial teams to secure product reimbursement and in the planning and execution of product launches.
Lance has an M.S. in pharmaceutical medicine from Hibernia College and received his MB.ChB (Bachelor of Medicine and Surgery) from the University of Cape Town.